These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 31503443)

  • 1. Collagenase Nanoparticles Enhance the Penetration of Drugs into Pancreatic Tumors.
    Zinger A; Koren L; Adir O; Poley M; Alyan M; Yaari Z; Noor N; Krinsky N; Simon A; Gibori H; Krayem M; Mumblat Y; Kasten S; Ofir S; Fridman E; Milman N; Lübtow MM; Liba L; Shklover J; Shainsky-Roitman J; Binenbaum Y; Hershkovitz D; Gil Z; Dvir T; Luxenhofer R; Satchi-Fainaro R; Schroeder A
    ACS Nano; 2019 Oct; 13(10):11008-11021. PubMed ID: 31503443
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Co-encapsulation of collagenase type I and silibinin in chondroitin sulfate coated multilayered nanoparticles for targeted treatment of liver fibrosis.
    Luo J; Zhang Z; Zeng Y; Dong Y; Ma L
    Carbohydr Polym; 2021 Jul; 263():117964. PubMed ID: 33858569
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mild Acid-Responsive "Nanoenzyme Capsule" Remodeling of the Tumor Microenvironment to Increase Tumor Penetration.
    Yao H; Guo X; Zhou H; Ren J; Li Y; Duan S; Gong X; Du B
    ACS Appl Mater Interfaces; 2020 May; 12(18):20214-20227. PubMed ID: 32248684
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Partial ligand shielding nanoparticles improve pancreatic ductal adenocarcinoma treatment via a multifunctional paradigm for tumor stroma reprogramming.
    Zhao T; Zhang R; He Q; Zhou H; Song X; Gong T; Zhang Z
    Acta Biomater; 2022 Jun; 145():122-134. PubMed ID: 35381402
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sono-promoted drug penetration and extracellular matrix modulation potentiate sonodynamic therapy of pancreatic ductal adenocarcinoma.
    Xiao H; Li X; Li B; Zhong Y; Qin J; Wang Y; Han S; Ren J; Shuai X
    Acta Biomater; 2023 Apr; 161():265-274. PubMed ID: 36893956
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathophysiological role of microRNA-29 in pancreatic cancer stroma.
    Kwon JJ; Nabinger SC; Vega Z; Sahu SS; Alluri RK; Abdul-Sater Z; Yu Z; Gore J; Nalepa G; Saxena R; Korc M; Kota J
    Sci Rep; 2015 Jun; 5():11450. PubMed ID: 26095125
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intelligent micelles for on-demand drug delivery targeting extracellular matrix of pancreatic cancer.
    Li C; Chen Q; Jiang C
    J Control Release; 2024 Sep; 373():879-889. PubMed ID: 39098554
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extracellular matrix modulating enzyme functionalized biomimetic Au nanoplatform-mediated enhanced tumor penetration and synergistic antitumor therapy for pancreatic cancer.
    Yang XY; Zhang JG; Zhou QM; Yu JN; Lu YF; Wang XJ; Zhou JP; Ding XF; Du YZ; Yu RS
    J Nanobiotechnology; 2022 Dec; 20(1):524. PubMed ID: 36496411
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A bioengineered heterotypic stroma-cancer microenvironment model to study pancreatic ductal adenocarcinoma.
    Drifka CR; Eliceiri KW; Weber SM; Kao WJ
    Lab Chip; 2013 Oct; 13(19):3965-75. PubMed ID: 23959166
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased fibrosis and impaired intratumoral accumulation of macromolecules in a murine model of pancreatic cancer co-administered with FGF-2.
    Sakai S; Iwata C; Tanaka HY; Cabral H; Morishita Y; Miyazono K; Kano MR
    J Control Release; 2016 May; 230():109-15. PubMed ID: 27080571
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Collagenase-Encapsulated pH-Responsive Nanoscale Coordination Polymers for Tumor Microenvironment Modulation and Enhanced Photodynamic Nanomedicine.
    Liu J; Tian L; Zhang R; Dong Z; Wang H; Liu Z
    ACS Appl Mater Interfaces; 2018 Dec; 10(50):43493-43502. PubMed ID: 30468076
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differences in Nanoparticle Uptake in Transplanted and Autochthonous Models of Pancreatic Cancer.
    Tao Z; Muzumdar MD; Detappe A; Huang X; Xu ES; Yu Y; Mouhieddine TH; Song H; Jacks T; Ghoroghchian PP
    Nano Lett; 2018 Apr; 18(4):2195-2208. PubMed ID: 29533667
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synergistic cytotoxicity and co-autophagy inhibition in pancreatic tumor cells and cancer-associated fibroblasts by dual functional peptide-modified liposomes.
    Chen X; Yu Q; Liu Y; Sheng Q; Shi K; Wang Y; Li M; Zhang Z; He Q
    Acta Biomater; 2019 Nov; 99():339-349. PubMed ID: 31499197
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Generation of an in vitro 3D PDAC stroma rich spheroid model.
    Ware MJ; Keshishian V; Law JJ; Ho JC; Favela CA; Rees P; Smith B; Mohammad S; Hwang RF; Rajapakshe K; Coarfa C; Huang S; Edwards DP; Corr SJ; Godin B; Curley SA
    Biomaterials; 2016 Nov; 108():129-42. PubMed ID: 27627810
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A tunable delivery platform to provide local chemotherapy for pancreatic ductal adenocarcinoma.
    Indolfi L; Ligorio M; Ting DT; Xega K; Tzafriri AR; Bersani F; Aceto N; Thapar V; Fuchs BC; Deshpande V; Baker AB; Ferrone CR; Haber DA; Langer R; Clark JW; Edelman ER
    Biomaterials; 2016 Jul; 93():71-82. PubMed ID: 27082874
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting the tumor microenvironment for pancreatic ductal adenocarcinoma therapy.
    Zhang YF; Jiang SH; Hu LP; Huang PQ; Wang X; Li J; Zhang XL; Nie HZ; Zhang ZG
    Chin Clin Oncol; 2019 Apr; 8(2):18. PubMed ID: 31070038
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gradient tumor microenvironment-promoted penetrating micelles for hypoxia relief and immunosuppression reversion in pancreatic cancer treatment.
    Luo Y; Li C; Zhang Y; Liu P; Chen H; Zhao Z; Wang Y; Zhou Z; Song H; Su B; Li C; Li X; Zhang T; You H; Wu Y; Tian Z; Zhang S; Guo Y; Fan H; Chen Q; Jiang C; Sun T
    Acta Biomater; 2023 Sep; 167():387-400. PubMed ID: 37276955
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Delivery of miR-212 by chimeric peptide-condensed supramolecular nanoparticles enhances the sensitivity of pancreatic ductal adenocarcinoma to doxorubicin.
    Chen W; Zhou Y; Zhi X; Ma T; Liu H; Chen BW; Zheng X; Xie S; Zhao B; Feng X; Dang X; Liang T
    Biomaterials; 2019 Feb; 192():590-600. PubMed ID: 30553134
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic efficacy of anti-MMP9 antibody in combination with nab-paclitaxel-based chemotherapy in pre-clinical models of pancreatic cancer.
    Awasthi N; Mikels-Vigdal AJ; Stefanutti E; Schwarz MA; Monahan S; Smith V; Schwarz RE
    J Cell Mol Med; 2019 Jun; 23(6):3878-3887. PubMed ID: 30941918
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nanotechnology-Based Strategy for Enhancing Therapeutic Efficacy in Pancreatic Cancer: Receptor-Targeted Drug Delivery by Somatostatin Analog.
    Gu X; Majumder J; Taratula O; Kuzmov A; Garbuzenko O; Pogrebnyak N; Minko T
    Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791582
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.